Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
PPD Development, LP, 7551 Metro Center Drive, Suite 200, Austin, Texas, United States
PPD Development, LP, Austin, Texas, United States
Carolina Research, Greenville, North Carolina, United States
Synexus Clinical Research US, Inc. - Anderson, Anderson, South Carolina, United States
Anaheim Clinical Trials LLC, Anaheim, California, United States
Carolina Research, Greenville, North Carolina, United States
Central Sooner Research, Norman, Oklahoma, United States
Biopharma Informatic, LLC, Houston, Texas, United States